Juan-Luis-Arranz-Cózar

Juan Luis Arranz Cozar

Médico Adjunto
Specialty:
Medical oncology
Serving specialties:
  • Oncología Médica
E-mail: jlarranz@quironsalud.es
Hospitals where he/she works:
  • Hospital Universitario Fundación Jiménez Díaz
Consultation: Room 6. 1st floor.
Opening times: 09:10 to 14:10
General Information
Experience

1. From October 2010 to present: Associate Physician (FEA) in Medical Oncology. Jiménez Díaz Foundation University Hospital, Madrid.
I am part of the breast cancer and CNS tumors unit.
I also have extensive experience in various oncological pathologies, including: sarcomas, cancer of unknown origin, neuroendocrine tumors, and rare tumors.
2. July 2009 to March 2010. Severo Ochoa University Hospital, Leganés. Associate Physician (FEA) in Medical Oncology. Head of the Digestive and Urological Tumors Department.

Degree
  • Graduate in Medicine and Surgery. Faculty of Medicine, Complutense University, Madrid, 1992–1998
  • Specialist in medical oncology. Medical Oncology Service. Gregorio Marañón University General Hospital. May 2005 – May 2009
  • Specialty in Family and Community Medicine. Getafe University Hospital. June 1999 – June 2002
Research and teaching

Research:

Sub-investigator of numerous clinical trials in breast cancer

Teaching:

Teaching collaborator at the UAM

Publications
  • 1. P. Khosravi, V. M. Diaz Muñoz de la Espada, P. Garcia Alfonso, S. Encinas Garcia, Y. Izarzugaza Peron, J. L. Arranz Cozar, B. Hernandez Marin and G. Perez Manga. "Management of Gastric Adenocarcinoma". Clin Trans Oncol (2007) 9:438-442.
  • 2. P. García Alfonso, V. Martínez Marín, A. Muñoz Martín, P. Khosravi, J.L. Arranz Cózar, J.M. Tellado Rodríguez. "Treatment of extrahepatic biliary tract cancer." Rev Cancer, Vol 22. No. 2, pp 74-85, 2008.
  • 3. AJ Muñoz Martin, V. Martínez, JL Arranz, L. Cabezón, R. González del Val, P. García Alfonso. "First line treatment of advanced gastric cancer and hepatic dysfunction with oxaliplatin, 5-fluorouracil and cetuximab." Clin Transl Oncol (2008) 10:182-184.
  • 4. Balance benefit? A cost analysis based on prescribing patterns in Spain." Clin Transl Oncol. 2014 Mar; 16(3):273-9. doi:10.1007/s12094-013-1068-3. Epub 2013 Jun 21.
  • 5. J Martinez-Trufero, R Alvarez Alvarez, A Lopez Pousa, I Sevilla, P Sancho Marquez, C Orbegoso, J Cruz Jurado, MA Sala Gonzalez, C Valverde Morales, MJ Blanco Sanchez, JA Pérez-Fidalgo, JP Berros, J Martinez García, JL Arranz, A Meana, JA López-Martín, J Rubió, JM Cano, I Juez-Martel, J Martin Broto. "MULTIDISCIPLINARY TREATMENT OUTCOME OF DESMOID-TYPE FIBROMATOSIS (DTF). A REGISTRY-BASED STUDY FROM SPANISH GROUP FOR RESEARCH ON SARCOMA (GEIS) Annals of Oncology 25(suppl 4):iv 507 · September 2014.
  • 6. J Cruz Jurado, C Valverde Morales, MA Vaz, R Alvarez Alvarez, A Lopez-Pousa, P Sancho Marquez, JA Carrasco, J Martinez-Trufero, MA Sala Gonzalez, JL Arranz, LM De, Sande González, MJ Blanco Sanchez, C Orbegoso, JA Pérez-Fidalgo, J Martinez García, J Lavernia, I Sevilla, JM Cano, A Meana, J Martin Broto. "SOLITARY FIBROUS TUMOR (SFT): A REGISTRY PROGRAM TO ASSESS FREQUENCY AND MANAGEMENT IN OUR COUNTRY. A SPANISH GROUP FOR RESEARCH ON SARCOMA (GEIS) STUDY" Annals of Oncology 25(suppl_4):494-510 · September 2014

BOOK CHAPTERS

  • 1. "Communication with elderly and adolescent patients" from the book "Communication in Oncology" published by SEOM in 2006.
  • 2. "Integration of targeted therapies in first-line colorectal cancer treatment" from the book "New therapeutic targets in colorectal cancer". P. García Alfonso, A. Muñoz, V. Martínez Marín, J.L. Arranz et al. Ed. Arán Ediciones SL, Madrid 2008. ISBN 978-84-96881-49-5.
  • 3. "Epidemiology of soft tissue sarcomas." ONCOSUR Guide. 2017.
  • 4. Case history. The HER2 metastatic breast cancer patient. Comparing experiences with Tucatinib. Carocci editori. 2024.
Communications and Presentations

1. "Efficacy and safety of first-line treatment with a combination of bevacizumab and biweekly XELIRI in metastatic colorectal cancer without previous treatment". P. García Alfonso, A. Muñoz Martín, R. González del Val, P. Khosravi, Y. Izarzugaza Peron, J.L. Arranz Cózar, L. Cabezón Gutierrez, I. Márquez-Rodas, A. Soria Lovelle, G. Pérez Manga. Poster 431. 2009 Gastrointestinal Cancers Symposium. January 16–18, 2009. San Francisco, California.
2. "Biweekly XELIRI plus Bevacizumab as first-line treatment for metastatic colorectal cancer (mCRC) patients". P. García Alfonso, AJ Muñoz Martín, V. Martínez Marín, R. González del Val, B. Hernández, P. Khosravi, S. Encinas, JL Arranz, Y. Izarzugaza, G. Pérez-Manga. PO-79. ICACT. 19th International Congress on Anticancer Treatment. Paris, 5-8 February 2008.
3. "Lymphomas in solid organ transplant recipients: data update from the HGU Gregorio Marañón". P-97, XI National Congress of the Spanish Society of Medical Oncology (SEOM). Madrid, 3-5 October 2007.
4. "Adjuvant treatment of high-risk melanoma with high-dose interferon alpha2B". A.J. Muñoz Martín, S. García Adrián, V. Martínez, B. Hernández, J.L. Arranz, R. Álvarez, L. Cabezón, P. García Alfonso, A. Alonso, G. Pérez-Manga. P-68, XI National Congress of the Spanish Society of Medical Oncology (SEOM). Madrid, 3-5 October 2007.
5. "Exploratory analysis of immunomodulation and apoptosis factors in alveolar soft-part sarcoma: a retrospective study from the Spanish Group for Research on Sarcoma (GEIS)" November 2016. Conference: Connective Tissue Oncology Society (CTOS) Annual Meeting

Awards and certifications
  • Specialist in medical oncology.
  • Medical specialists